DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, has executed a licensing agreement with strategic partner Creative Clinical Concepts (CCC) and its AspirinWorks® division. The agreement gives Corgenix full rights to CCC’s AspirinWorks® business, including the AspirinWorks® name.
